Biological Half-Life of Transfused Antihaemophilic Globulin (Factor VIII) In Normal Man
- 1 November 1967
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 13 (6), 822-828
- https://doi.org/10.1111/j.1365-2141.1967.tb08853.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag SystemNew England Journal of Medicine, 1965
- FURTHER EXPERIENCE IN USE OF HUMAN ANTIHÆMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTION IN HÆMOPHILIC PATIENTS: A REPORT TO THE MEDICAL RESEARCH COUNCIL'S WORKING PARTY ON HUMAN ANTIHÆMOPHILIC GLOBULINThe Lancet, 1965
- The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these FactorsBritish Journal of Haematology, 1963
- THE SURVIVAL OF FACTOR VIII (ANTIHEMOPHILIC GLOBULIN) AND FACTOR IX (PLASMA THROMBOPLASTIN COMPONENT) IN NORMAL HUMANS*Journal of Clinical Investigation, 1963
- Turnover of Prothrombin, Factor VII and Factor IX in a Patient with Hemophilia AScandinavian Journal of Clinical and Laboratory Investigation, 1961
- DISAPPEARANCE RATE OF CONCENTRATED PROCONVERTIN EXTRACTS IN CONGENITAL AND ACQUIRED HYPOPROCONVERTINEMIA*Journal of Clinical Investigation, 1960
- A Study of a Case of Congenital HypoprothrombinaemiaBritish Journal of Haematology, 1959